Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

Lawitz E, Flisiak R, Abunimeh M, et al. Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection. Liver Int. 2020;40(5):1032-1041.

Publication Type:

Journal Article

Authors:

Lawitz, E; Flisiak, R; Abunimeh, M; et, al

Source:

Liver Int, Volume 40, Issue 5, p.1032-1041 (2020)

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top